BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
SNCA
,
calcium channel activity
,
Obesity
,
Lung
,
Alcohol
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PDGF)-BB
Summary
General Info
Curated Studies
Most Correlated Studies
S17 stromal cell gene expression in response to treatment with PDGF-BB
Cardiomyocyte HL-1 cells cultured in serum free media with TGFB2 or PDGF BB
Bladder smooth muscle cells treated with platelet-derived growth factor (PDGF-BB) for 0, 4 or 24hr
PDGF-BB treated rat aortic smooth muscle cell gene expression and phenotypic modulation.
Aortic smooth muscle cells overexpressing fusion protein Myocd-LSD1 or treated with PDGF-BB
Explore Curated Studies Results
Literature
Most Relevant Literature
PDGF-BB accelerates TSCC via fibroblast lactates limiting miR-26a-5p and boosting mitophagy.
Atorvastatin rescues pulmonary artery hypertension by inhibiting the AKT/ERK-dependent PDGF-BB/HIF-1…
EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesi…
Clinical Outcome of Multiple Platelet-Rich Plasma Injection and Correlation with PDGF-BB in the Trea…
Cathepsin K inhibition alleviates periodontal bone resorption by promoting type H vessel formation t…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With…
A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chr…
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therap…
Efficacy of PRF Application on Clinical Parameters and GCF Platelet-derived Growth Factor-BB and Per…
Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ